Income statement
USD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -39K | -53K | -60K | -86K | -82K |
| EBITDA | -39K | -53K | 768K | 151K | -82K |
| Net Income | -42K | -54K | 525K | -142K | -506K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0059
-7.81% today
1Y Change
+39.13%
Window
Jun 23, 2025 → Jun 4, 2026
Coverage: 242 bars · Jun 23, 2025 → Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ProText Mobility, Inc. (TXTM) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.01 and up 39.1% across the available one-year price window (Jun 23, 2025 → Jun 4, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Valuation already assumes a fairly strong business story at P/E 108.5. Stock Foundry combines TXTM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TXTM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TXTM Max Drawdown
-60.77%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TXTM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$506.0K
-255.6% YoY
Free Cash Flow
-$78.4K
-2948.5% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -39K | -53K | -60K | -86K | -82K |
| EBITDA | -39K | -53K | 768K | 151K | -82K |
| Net Income | -42K | -54K | 525K | -142K | -506K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15M | 15M | 170K | 203K | 603K |
| Total Liabilities | 626K | 572K | 1M | 2M | 2M |
| Shareholder Equity | 14M | 14M | -1M | -2M | -1M |
| Total Debt | 62K | 9K | 70K | 302K | 299K |
| Net Debt | 62K | 9K | 70K | 302K | 299K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
78K
-2948.5% YoY
Capital Expenditures
0
Free Cash Flow
78K
-2948.5% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.